Navigation Links
New Research Shows: Neurofeedback is an 'Evidence-Based' Treatment for ADHD
Date:7/15/2009

NIJMEGEN, The Netherlands, July 16 /PRNewswire/ -- Neurofeedback - also called EEG Biofeedback - is a method used to train brain activity in order to normalize Brain function and treat psychiatric disorders. This treatment method has gained interest over the last 10 years, however the question whether this treatment should be regarded as an Evidence-Based treatment was unanswered until now. Tomorrow a study will be published in the scientific journal 'EEG and Clinical Neuroscience' demonstrating that Neurofeedback can indeed be regarded as an evidence-based treatment for Attention Deficit- / Hyperactivity Disorder (ADHD).

Neurofeedback is a treatment where real-time feedback is provided for specific brain activity (most often EEG) in order to learn the brain to suppress or produce specific brain activity. This method was initially discovered for the treatment of Epilepsy and from 1976 investigated further for the treatment of ADHD. This technique has become more popular by clinicians worldwide, and is currently provided for the treatment of several disorders. Critics have often questioned the efficacy of Neurofeedback and whether it can be considered an Evidence Based treatment or not.

In collaboration with researchers from Tubingen University (Germany), Radboud University (Nijmegen, the Netherlands), Brainclinics and EEG Resource Institute a so-called meta-analysis was conducted on all published research about Neurofeedback treatment in ADHD. This meta-analysis included 15 studies and 1194 ADHD patients. Based on this study - which will be published in the July issue of EEG and Clinical Neuroscience - it could be concluded that Neurofeedback can indeed be considered an Evidence-Based treatment for ADHD. The results show that neurofeedback treatment has large and clinically significant effects on Impulsivity and Inattention and a modest improvement of Hyperactivity.

These findings apply to
'/>"/>

SOURCE Brainclinics Treatment B.V.
Copyright©2009 PR Newswire.
All rights reserved

15

GOOD

Page: 1 2

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2010)... Vermillion, Inc. (Nasdaq: VRML ), a molecular diagnostics company, will host ... issuance of Q2 financial results on Monday, August 16, 2010 . ... Conference Call Information ... To access the ... United States and Canada or +1 212 231 2901 ...
(Date:7/29/2010)... response to the agreement announced that CVS Caremark would provide pharmacy ... the National Community Pharmacists Association (NCPA) issued the following statement from ... H. Harmison , PD: , ... (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) , ... (Logo: http://www.newscom.com/cgi-bin/prnh/20100106/DC33253LOGO ) , ...
(Date:7/29/2010)... , July 29 ... from a Phase Ib/II clinical trial in ... unique, investigational new drug for the treatment ... endpoint demonstrating that ITI-007 was safe and ... addition, several exploratory endpoints were evaluated. Treatment ...
Breaking Medicine Technology:Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 2Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 3NCPA Statement on CVS Caremark-Aetna Agreement 2NCPA Statement on CVS Caremark-Aetna Agreement 3Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 2Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 3Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 4Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 5Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia 6Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 1Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 2Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 3Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 4Nautilus IDScan net Presents New Drivers 26apos 3B License Parsing Component a Magic Tool for Software Developers 71238 5MarijuanaDoctors com Announces Weed Team Contest Winner Adds Additional Trip to the Cannabis Cup in Amsterdam 71236 1MarijuanaDoctors com Announces Weed Team Contest Winner Adds Additional Trip to the Cannabis Cup in Amsterdam 71236 2MarijuanaDoctors com Announces Weed Team Contest Winner Adds Additional Trip to the Cannabis Cup in Amsterdam 71236 3New Book Reveals the Powerful and Undermining Impact of Stress on Good Decision Making and What Leaders Can Do About It 71233 1New Book Reveals the Powerful and Undermining Impact of Stress on Good Decision Making and What Leaders Can Do About It 71233 2New Book Reveals the Powerful and Undermining Impact of Stress on Good Decision Making and What Leaders Can Do About It 71233 3
... Oncolytics,Biotech Inc. ("Oncolytics") announces that a poster by ... York, entitled "In Vivo Synergy between,Oncolytic Reovirus and ... be presented today at the American,Association for Cancer ... meeting runs from April 14-18, 2007. , The ...
... WIRE)--Apr 17, 2007 - ZIOPHARM Oncology,Inc. (NASDAQ: ... strongly supportive of the development of an ... high,bioavailability when administered orally; in addition it ... to oral,administration. These data were presented in ...
Other Medicine Technology:Oncolytics Biotech Inc. Research Collaborators Demonstrate,Reovirus/Gemcitabine Combination Has Synergistic Effect Against,Human Colon Cancer Cell Lines 2Oncolytics Biotech Inc. Research Collaborators Demonstrate,Reovirus/Gemcitabine Combination Has Synergistic Effect Against,Human Colon Cancer Cell Lines 3ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR 2ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR 3
(Date:7/29/2010)... HealthDay Reporter , , THURSDAY, July 29 (HealthDay News) -- ... a better predictor of how well a woman will ... been the traditional way of looking at cancers, new ... the genetic makeup of 595 breast cancer tumors and ... used algorithms to separate the tumors into eight types ...
(Date:7/29/2010)... Administration (FDA) received reports of malignancies in children using ... an associated risk and prompting an investigation. Researchers from ... malignancy in children using infliximab, etanercept, and adalimumab and ... Arthritis & Rheumatism , a journal of the ... approved 3 TNF blockers for use in children: Etanercept ...
(Date:7/29/2010)... , , THURSDAY, July 29 (HealthDay News) -- New research ... the risk of broken bones in postmenopausal women with ... risk seen among men who had been prescribed either ... isn,t the first time such an association has been ... belong to the class of medications known as thiazolidinediones ...
(Date:7/29/2010)... history of male breast cancer perceive themselves to be at ... a family history of female breast cancer; however those with ... know about or seek genetic testing than those with a ... led by researchers at the University of Louisville,s James Graham ... accounts for only about one percent of all breast cancers, ...
(Date:7/29/2010)... new study from Perth,s Telethon Institute for Child Health ... diet in adolescents. , The research findings have just ... Attention Disorders . , Leader of Nutrition studies at ... examined the dietary patterns of 1800 adolescents from the ... ,Western, patterns. , "We found a diet high ...
Breaking Medicine News(10 mins):Health News:Breast Cancer's DNA Yields More Secrets 2Health News:Breast Cancer's DNA Yields More Secrets 3Health News:TNF blockers may increase the risk of malignancy in children 2Health News:TNF blockers may increase the risk of malignancy in children 3Health News:New Data Supports Link Between Diabetes Drugs, Fractures 2Health News:New Data Supports Link Between Diabetes Drugs, Fractures 3Health News:Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling 2Health News:Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling 3Health News:Western diet link to ADHD 2
... June 15, 2006 issue of CANCER, a peer-reviewed journal ... radiation// could be a treatment option for men aged ... ,Age has remained a controversial factor, which dictates ... recommend more aggressive therapy as compared to older individuals. ...
... is a generally accepted fact that the doses given ... it is not always clear, how much is enough ... Children’s Center shows that making the dosage a computerized ... well. ,An online infusion calculator and a ...
... leading cardinal has urged Christians to initiate legal action against ... he feels that it offends Christ// and the Church as ... it is enough for us to forgive and to forget,' ... attempts to disclose a murder mystery associated with the life ...
... remembered of the 90 million odd volunteers belonging to the ... back bone of the movement//, and whose helping hand is ... needy all over the world. , ,These unsung heroes ... risking their lives at times, in order to help others ...
... die every day in Madhya Pradesh due to pregnancy related complications, ... ,According to data from the National Family Health Survey (NFHS), the ... which means that out of every 100,000 women, 498 die either ... mother. ,Taking the Census figures, about 1.9 million ...
... apply for a separate insurance scheme as they would no ... may feel that they can go without insurance to save ... or diagnosed with a serious medical problem. Even those ... a few months since there's often a waiting period before ...
Other Medicine News:Health News:Dispensing Drug Dosage To Children Through Computers 2Health News:Dispensing Drug Dosage To Children Through Computers 3Health News:Dispensing Drug Dosage To Children Through Computers 4Health News:Salutations For The Selfless Heroes On World Red Cross Day 2Health News:At Least 25 Women Die Of Maternity Complications In MP Everyday 2Health News:Insurance Plans after Graduation 2
Eschenbach's new 2636 series of stand magnifiers delivers the benefits of high power and a large fields of view. Using a unique doublet lens design, the 2636 offers the highest power recatngular lens...
The Multi-Purpose Stand Magnifier is the most versatile stand magnifier. The stand has multiple configurations allowing for all situations where hands-free magnification is needed....
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Bausch & Lomb round and rectangular magnifiers incorporate precision optics and an ergonomic design for increased clarity and comfort during use...
Medicine Products: